CRD SUMMARY: The authors concluded that protamine administration after percutaneous coronary intervention appeared to be safe and was associated with a significant reduction in major bleeding complications. Uncertainty with regard to the selection and quality of included studies means that even this tentative conclusion proposed by the authors might not be reliable.
